Independent CE-Accredited Satellite Dinner Symposium: The Amazing Case: Charting the Course of Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Relapsed/Refractory Follicular Lymphoma with Bispecific Antibodies
Overview Join us for this game-style symposium on relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) and R/R follicular lymphoma (FL) with treatment consideration for bispecific antibodies designed to encourage the exchange of ideas between leaders in the field and attendees. During this engaging session, 3 expert faculty will present clinical data with real-world practical considerations using patient cases to highlight best practices for integrating novel therapies into clinical practice. Throughout the presentation the audience will have the opportunity to participate in a group competition with the winners announced at the end of the session. Lastly, the faculty will field questions from the audience during a Q&A segment, enhancing the potential to discuss impactful treatment options.
Learning Objectives:
Have increased knowledge regarding the
Available bispecific antibodies for the treatment of R/R non-Hodgkin lymphoma (NHL)
Have greater competence related to
Administering bispecific antibodies in clinical practice
Have greater competence related to
Managing adverse events of bispecific antibodies used for the treatment of R/R NHL
Demonstrate greater confidence in their ability to
Safely use bispecific antibodies as part of the treatment plan for patients with R/R NHL
